Eneida R. Nemecek

10.6k total citations
33 papers, 794 citations indexed

About

Eneida R. Nemecek is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Eneida R. Nemecek has authored 33 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 13 papers in Hematology and 9 papers in Oncology. Recurrent topics in Eneida R. Nemecek's work include Hematopoietic Stem Cell Transplantation (10 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Eneida R. Nemecek is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Eneida R. Nemecek collaborates with scholars based in United States, Canada and Nigeria. Eneida R. Nemecek's co-authors include Joanne Kurtzberg, Susan E. Prockop, Sonali Chaudhury, Lolie C. Yu, Biljana Horn, Julie‐An Talano, Pierre Teira, Victor Lewis, Henrique Bittencourt and Ka Wah Chan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cochrane Database of Systematic Reviews.

In The Last Decade

Eneida R. Nemecek

30 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eneida R. Nemecek United States	15	348	261	172	135	131	33	794
Roberta H. Adams United States	15	192 0.6×	371 1.4×	148 0.9×	172 1.3×	71 0.5×	53	818
Dolors Costa Spain	21	417 1.2×	400 1.5×	299 1.7×	190 1.4×	97 0.7×	73	1.2k
Renato Fanin Italy	17	291 0.8×	367 1.4×	135 0.8×	251 1.9×	76 0.6×	40	797
Panayotis Kaloyannidis Greece	15	217 0.6×	168 0.6×	131 0.8×	132 1.0×	49 0.4×	41	628
Nuray Kuşadasi Netherlands	12	147 0.4×	237 0.9×	140 0.8×	125 0.9×	156 1.2×	21	622
Rafael Forés Spain	17	368 1.1×	525 2.0×	96 0.6×	151 1.1×	42 0.3×	47	818
Duncan Purtill Australia	15	326 0.9×	583 2.2×	69 0.4×	175 1.3×	47 0.4×	59	790
Karan Saluja United States	14	154 0.4×	284 1.1×	114 0.7×	76 0.6×	46 0.4×	56	679
Fumitaka Nagamura Japan	16	225 0.6×	543 2.1×	238 1.4×	277 2.1×	37 0.3×	53	1.0k
Chunji Gao China	16	256 0.7×	360 1.4×	258 1.5×	226 1.7×	27 0.2×	77	897

Countries citing papers authored by Eneida R. Nemecek

Since Specialization

Citations

This map shows the geographic impact of Eneida R. Nemecek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eneida R. Nemecek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eneida R. Nemecek more than expected).

Fields of papers citing papers by Eneida R. Nemecek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eneida R. Nemecek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eneida R. Nemecek. The network helps show where Eneida R. Nemecek may publish in the future.

Co-authorship network of co-authors of Eneida R. Nemecek

This figure shows the co-authorship network connecting the top 25 collaborators of Eneida R. Nemecek. A scholar is included among the top collaborators of Eneida R. Nemecek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eneida R. Nemecek. Eneida R. Nemecek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Auletta, Jeffery J., Jennifer Holter‐Chakrabarty, Pashna N. Munshi, et al.. (2024). Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplantation and Cellular Therapy. 30(12). 1124–1138. 2 indexed citations

Nikiforow, Sarah, Jennifer Whangbo, Ran Reshef, et al.. (2024). Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol. Blood Advances. 8(12). 3001–3012. 8 indexed citations

Auletta, Jeffery J., Jennifer Holter‐Chakrabarty, Tania Jain, et al.. (2023). Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplantation and Cellular Therapy. 29(12). 739–746. 6 indexed citations

Auletta, Jeffery J., et al.. (2022). The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem. Transplantation and Cellular Therapy. 28(12). 802–809. 25 indexed citations

Carpenter, Paul A., Hyoung Jin Kang, Keon Hee Yoo, et al.. (2022). Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study. Transplantation and Cellular Therapy. 28(11). 771.e1–771.e10. 18 indexed citations

Kurtzberg, Joanne, Susan E. Prockop, Sonali Chaudhury, et al.. (2020). Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in Children. Biology of Blood and Marrow Transplantation. 26(5). 855–864. 51 indexed citations

Kurtzberg, Joanne, Hisham Abdel‐Azim, Paul A. Carpenter, et al.. (2020). A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 26(5). 845–854. 117 indexed citations

Prockop, Susan E., Robert A. Baiocchi, Nancy Bunin, et al.. (2018). Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder. Biology of Blood and Marrow Transplantation. 24(3). S41–S42. 6 indexed citations

Duncan, Christine, Ruta Brazauskas, Jiaxing Huang, et al.. (2018). Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation. 53(10). 1278–1287. 27 indexed citations

10.

Locatelli, Franco, Annalisa Ruggeri, Pietro Merli, et al.. (2018). Administration of BPX-501 Cells Following Aβ T and B-Cell-Depleted HLA Haploidentical HSCT (haplo-HSCT) in Children with Acute Leukemias. Blood. 132(Supplement 1). 307–307. 4 indexed citations

11.

Burroughs, Lauri M., Akiko Shimamura, Julie‐An Talano, et al.. (2017). Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders. Biology of Blood and Marrow Transplantation. 23(10). 1669–1677. 37 indexed citations

12.

Florescu, Diana F., David F. Mercer, Michael Grimley, et al.. (2014). Brincidofovir (CMX001) for the Treatment of Serious or Life-Threatening Double-Stranded DNA Virus Infections in Patients Receiving Liver Transplant as Part of Multiorgan Transplantation.. Transplantation. 98. 662–662. 2 indexed citations

13.

Kurtzberg, Joanne, Susan E. Prockop, Pierre Teira, et al.. (2013). Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients. Biology of Blood and Marrow Transplantation. 20(2). 229–235. 178 indexed citations

14.

Oringanje, Chioma, et al.. (2013). Hematopoietic stem cell transplantation for people with sickle cell disease. Cochrane Database of Systematic Reviews. CD007001–CD007001. 4 indexed citations

15.

Szabolcs, Paul, Giuseppe Visani, Franco Locatelli, et al.. (2010). Treatment Of Steroid-Refractory Acute GVHD With Mesenchymal Stem Cells Improves Outcomes In Pediatric Patients; Results Of The Pediatric Subset In A Phase III Randomized, Placebo-Controlled Study. Biology of Blood and Marrow Transplantation. 16(2). S298–S298. 21 indexed citations

16.

Oringanje, Chioma, et al.. (2009). Hematopoietic stem cell transplantation for children with sickle cell disease. Cochrane Database of Systematic Reviews. CD007001–CD007001. 12 indexed citations

17.

Nemecek, Eneida R., Damian J. Green, Darrell R. Fisher, et al.. (2008). Extracorporeal Adsorption Therapy: A Method to Improve Targeted Radiation Delivered by Radiometal-Labeled Monoclonal Antibodies. Cancer Biotherapy and Radiopharmaceuticals. 23(2). 181–191. 5 indexed citations

18.

Nemecek, Eneida R., et al.. (2003). Treatment of Neuroblastoma in Patients With Neurocristopathy Syndromes. Journal of Pediatric Hematology/Oncology. 25(2). 159–162. 9 indexed citations

19.

Nemecek, Eneida R. & Dana C. Matthews. (2003). Use of radiolabeled antibodies in the treatment of childhood acute leukemia. Pediatric Transplantation. 7(s3). 89–94. 7 indexed citations

20.

Nemecek, Eneida R. & Dana C. Matthews. (2002). Antibody-based therapy of human leukemia. Current Opinion in Hematology. 9(4). 316–321. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact